Measuring coping in multiple sclerosis: The Coping Index-MS

Author:

Young Carolyn A1ORCID,Mills Roger J1,Langdon Dawn2,Rog David J3,Sharrack Basil4,Kalra Seema5,Majeed Tahir6,Footit David7,Harrower Tim8,Nicholas Richard S9ORCID,Ford Helen L10ORCID,Woolmore John11,Johnstone Clare12,Thorpe John13,Paling David14,Ellis Cathy15,Hanneman C Oliver16,Tennant Alan17

Affiliation:

1. The Walton Centre NHS Foundation Trust, Liverpool, UK/University of Liverpool, Liverpool, UK

2. Royal Holloway, University of London, Egham, UK

3. Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Salford, UK

4. Academic Department of Neurology, The University of Sheffield, Sheffield, UK

5. University Hospital of North Midlands NHS Trust, Stoke-on-Trent, UK

6. Lancashire Teaching Hospitals, Preston, UK

7. Cumbria Partnership NHS Foundation Trust, Carlisle, UK

8. University of Exeter, Exeter, UK

9. Charing Cross Hospital, London, UK

10. Leeds Teaching Hospitals NHS Trust, Leeds, UK

11. Queen Elizabeth Hospital, Birmingham, UK

12. York and Scarborough Teaching Hospitals NHS Foundation Trust, York, UK

13. Peterborough City Hospital, Peterborough, UK

14. Royal Hallamshire Hospital, Sheffield, UK

15. Dartford & Gravesham NHS Trust, Dartford, UK

16. University of Plymouth, Plymouth, UK

17. Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK

Abstract

Background: Coping in multiple sclerosis (MS) refers to cognitive and behavioural efforts to manage stresses imposed by the illness. Existing generic and disease-specific coping scales do not meet modern guidelines for scale development and cannot produce interval-level metrics to allow for change scores. Objective: The main aim of this study was to develop a brief patient-reported outcome measure for coping in MS, capable of interval-level measurement. Methods: Qualitative work in 43 people with MS leads to a draft scale which was administered to 5747 participants, with longitudinal collection in 2290. A calibration sample of 1000 subjects split into development and validation sets was used to generate three scales consistent with Rasch model expectations. Results: The total Coping Index-MS (CI-MS-T), CI-MS-Internal (CI-MS-I) and CI-MS-External (CI-MS-E) cover total, internal and externally focused coping. All three scales are capable of interval-level measurement. Trajectory analysis of 9000 questionnaires showed two trajectories in CI-MS-T: Group 1 showed a low level of coping with slight decline over 40 months, while Group 2 had a better and stable level of coping due to improving CI-MS-I which compensated for the deteriorating CI-MS-E over time. CI-MS-T < 30 identified group membership at baseline. Conclusion: The CI-MS-T, CI-MS-I and CI-MS-E, comprising 20 items, provide interval-level measurement and are free-for-use in not-for-profit settings.

Funder

Roche

Merck Serono

Multiple Sclerosis Society

Biogen Idec

Genzyme

Novartis

Neurological Disability Fund 4530

Teva

Publisher

SAGE Publications

Subject

Neurology (clinical),Neurology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Prevalence, treatment and correlates of depression in multiple sclerosis;Multiple Sclerosis and Related Disorders;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3